Candriam SCA’s Nu Skin NUS Stock Holding History

Candriam SCA’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-60,171	Closed	-$3.05M	–	836
2021 Q4	$3.05M	Hold	60,171	–	–	0.02%	463
2021 Q3	$2.44M	Sell	60,171 -3,700	-6%	-$187K	0.02%	544
2021 Q2	$3.62M	Buy	63,871 +30,296	+90%	+$1.72M	0.02%	467
2021 Q1	$1.76M	Hold	33,575	–	–	0.01%	539
2020 Q4	$1.83M	Buy	+33,575	New	+$1.77M	0.01%	551
2018 Q2	–	Sell	-7,000	Closed	-$516K	–	818
2018 Q1	$516K	Buy	+7,000	New	+$497K	0.01%	672

Other funds holding NUS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Candriam SCA's NUS Position: Q1 2022 in Review

Candriam SCA sold out of Nu Skin (NUS) in Q1 2022, closing a stake of 60,171 shares — an estimated $3.05M sold.

Candriam SCA first reported a position in NUS in Q1 2018 and held it in 6 quarters. The position peaked at $3.62M in Q2 2021. 238 funds tracked by Wall St. Rank hold NUS as of Q1 2022.

Candriam SCA reported no remaining Nu Skin position as of Q1 2022 after selling out during the quarter.
Candriam SCA sold 60,171 Nu Skin shares in Q1 2022, an estimated $3.05M.
Candriam SCA first reported a position in Nu Skin in Q1 2018 and held it in 6 quarters.
Candriam SCA's Nu Skin position peaked at $3.62M in Q2 2021.
238 funds tracked by Wall St. Rank held Nu Skin as of Q1 2022.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.